Major depressive disorder accounts for the most years lived with disability worldwide and cardiovascular diseases are the leading cause of death globally. These conditions are co-morbid and exhibit sexual divergence in prevalence and severity. Furthermore, stress exposure is an environmental risk factor for the onset of both mood and cardiovascular symptoms. However, the neural processes that integrate stress effects on affective and cardiovascular outcomes are unknown. Human imaging studies indicate that both sad stimuli and autonomic processes activate the ventral medial prefrontal cortex (vmPFC). In rodents, the infralimbic (IL) portion of vmPFC modulates physiological stress responses, leading us to hypothesize that IL pyramidal neurons integrate depression-relevant behaviors with cardiovascular and endocrine stress reactivity. In the current study, an optogenetic approach targeted channelrhodopsin-2 expression to IL glutamatergic neurons in male and female rats. Animals were then assessed for stimulation preference and social motivation. Additionally, radiotelemetry and echocardiography were used to examine cardiovascular stress responses and chronic stress effects on cardiac structure and function. Our results indicate that IL glutamate neurons increased place preference and social motivation in males without affecting socio-motivational behaviors in females. IL activation also reduced endocrine and cardiovascular stress responses in males, while increasing reactivity in females. Moreover, prior IL stimulation protected males from subsequent chronic stress-induced sympatho-vagal imbalance and cardiac hypertrophy. In contrast, females were resistant to stress-induced hypertrophy, yet IL stimulation increased cardiac contractility after chronic stress. Collectively, the data suggest that cortical regulation of behavior, physiological stress responses, and cardiovascular outcomes fundamentally differ between sexes.
Major depressive disorder accounts for the most years lived with disability worldwide and cardiovascular diseases are the leading cause of death globally. These conditions are co‐morbid and exhibit sexual divergence in prevalence and severity. Furthermore, stress exposure is an environmental risk factor for the onset of both mood and cardiovascular symptoms. However, the neural processes that integrate stress effects on affective and cardiovascular outcomes are unknown. Human imaging studies indicate that both sad stimuli and autonomic processes activate the ventral medial prefrontal cortex (vmPFC). In rodents, the infralimbic (IL) portion of vmPFC modulates physiological stress responses, leading us to hypothesize that IL pyramidal neurons integrate depression‐relevant behaviors with cardiovascular and endocrine stress reactivity. To test this hypothesis, an optogenetic approach targeted channelrhodopsin‐2 expression to IL glutamatergic neurons in male and female rats. Animals were then assessed for stimulation preference and social motivation. The effects of IL stimulation were also determined for corticosterone and glucose reactivity to stress. Additionally, radiotelemetry and echocardiography were used to examine cardiovascular stress responses and chronic stress effects on cardiac structure and function. Our results show that, in males, IL pyramidal neuron activity was preferred, increased social motivation, and inhibited acute physiological stress reactivity by reducing corticosterone, glucose, heart rate, and arterial pressure. Intriguingly, prior IL activation lowered net cardiac sympathetic drive and protected against subsequent myocardial remodeling after chronic stress. However, IL activity had fundamentally different regulatory effects in females. Stimulation did not have motivational valence or alter social behavior but increased glucose and heart rate reactivity to acute stress and cardiac contractility following chronic stress. Collectively, these findings identify sexual divergence in the cortical integration of affective and physiological systems, suggesting that vmPFC output signaling may differentially impact health outcomes in males and females.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.